Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy.

J Immunother Cancer · 2024 · PMC11284826 · PMID 39060021

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

failed to reach significancep=0.056so close (0.05 < p ≤ 0.1)

Of note, differences in the PV density of CD69+NK cells in ADT-treated versus control tumors failed to reach significance (p=0.056) ( online supplemental figure 5D ).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.